To follow me click the "Follow" button! (Easy right?) Kumquat Research is a college student and fund manager who has been investing for 4 years. He writes mostly about the technology sector and about event-driven and momentum opportunities across various industries and sectors. He is currently studying for degrees in both finance and computer science at the University of Maryland. Some of his interests include technology, software engineering, drumming, video games (developing and playing) and astronomy.
As I'm a long-term investor, I'll highlight some stockpicks which will have a 5-7 year investment horizon. As I strongly believe a portfolio should consist of a mixture of dividend-paying stocks and growth stocks, my articles will reflect my thoughts on this mixture.
I have more than 7 years experience investing in commodities and hard assets such as gold and silver miners, exploration companies, oil and gas producers, MLPs, and various other sectors.
I am a lecturer at the University of Economics in Bratislava, department of Banking and International Finance. I have a Ph.D. academic degree, my dissertation was focused on commodity markets. Commodities and stock markets are also the main focus of my research and publication activitities.
I have approximately 10 years of investing experiences. My investments mostly focus on small- to mid-cap companies of resource sector, utilities and biotechnologies. I prefer long positions. I never short.
I am an undergraduate student (UQAC) living in Quebec, Canada.
I consider myself as a deep-value investor.
Getting my CFA designation is definitely an objective for the future. Feel free to send me an email for any questions.
Thanks for reading.
Email adress: firstname.lastname@example.org
I'm a trader who trades both short-term and long-term. I started my career as a day-trader for a trading firm, but then turned to longer time frames and went on my own to manage my portfolio.
I use technical analysis as well as fundamental analysis in my research.
I have a B.S. in Chemical Engineering from the University of Maryland and have worked on FDA clinical trials in the medical device industry for the last 10 years. I have more than 25 years investing experience.
Our investment philosophy primarily resides in buying equities for long term investments. However, we do enter trading positions primarily in the options and futures market to take advantage of situations as they arise (VIX and energy trades).
Our background includes:
-Applied science perspective with an Engineering background
-Health science perspective with a Registered Nurse background
-Finance perspective with an MBA background
Spent my entire 28 year career on Wall Street with over a decade at Bear Stearns. No "Wall Street Titan" in real life but WST is an alias that I've used for years on Yahoo so I use it when I write on SA. I have gained a significant amount of knowledge regarding the stem cell sector over the years and have recently launched a premium service covering this exciting area.
Founder and Lead Analyst at Lone Wolf Publications Ltd (www.lonewolftrader.com).
I also manage a private investment portfolio full time, and also provide mutual fund analysis and buy recommendations to individual investors managing their own investments.
I trade for myself via ETFs and futures markets, with interests in commodities generally and a special interest in precious metals.
Andy Hecht is the chief market strategist for Carden Capital and Carden Futures. Andy is a sought-after commodity and futures trader, an options expert and analyst. He spent nearly 35 years on Wall Street, including two decades on the trading desk of Phillip Brothers, which became Salomon Brothers and ultimately part of Citigroup.
Over the past two decades, he has researched, structured and executed some of the largest trades ever made, involving huge quantities of precious metals and bulk commodities.
Andy understands the market in a way many traders can’t imagine. He’s booked vessels, armored cars and trains to transport and store a wide range of commodities. And he’s worked directly with The United Nations and the legendary trading group Phibro.
Today, Andy remains in close contact with sources around the world and his network of traders.
“I have a vast Rolodex of information in my head… so many bull and bear markets. When something happens, I don’t have to think. I just react. History does tend to repeat itself over and over.”
His friends and mentors include highly regarded energy and precious metals traders, supply line specialists and international shipping companies that give him vast insight into the market.
Andy’s writing and analysis can be found on a number of market based websites including CQG. Andy lectures at colleges and Universities. He also contributes to Traders Magazine. He consults for companies involved in producing and consuming commodities. Andy's biweekly radio show, The Commodities Hour with Andy Hecht, can be heard on Tuesdays and Thursdays from 5-6 PM EST on www.tfnn.com. Andy’s first book How to Make Money with Commodities, published by McGraw Hill was released in 2013 and has received excellent reviews. He is currently working on his second book, Luster. Andy held a Series 3 and Series 30 license from the National Futures Association and is associated as a collaborator and strategist with hedge funds. Andy is the commodity-expert for the website about.com and blogs on his own site technomentals.com.
Greg Troccoli – Co-Founder Partner Greg is the founder of Chartlabpro.com, and has been providing institutional quality technical analysis for over 25 years. A majority of Greg’s career was spent at Prudential Securities, where he held the position of Chief Technical Analyst, covering all global markets. He in addition spent many years at Bear Sterns, and more recently Deutsche Bank-Americas. Greg’s research has been utilized by over 3,500 institutions worldwide, including eight central banks, proprietary trading desks and a large contingent of retail investors and financial advisors. Greg is regularly featured in the media. He is a weekly contributor on CNBC’s Fast Money, Closing Bell, Bloomberg TV and Yahoo Finance.
Louis Lukac – Head of Algorithmic Trading Louis Lukac was the former Director of Futures Research at Prudential Securities. In 1990, along with Jack Schwager he founded Wizard Trading. His pedigree includes system design while he was still an undergraduate at Purdue University. The Wizard Global Systematic Program employs computer assisted trading strategies based principally on technical analysis. Technical analysis uses internal market data (e.g., price, volume, open interest, sentiment) to determine price trends. No discretionary intervention has been utilized although the Advisor does reserve the right to utilize its discretion in extraordinary circumstances. The program uses a wide spectrum of strategies including trend following, countertrend, and pattern recognition approaches developed and streamlined over many years of research. Additionally, this program incorporates a volatility adjusted portfolio allocation method developed initially by Louis Lukac and Jack Schwager. The program attempts to optimize position size on a daily basis based on the relative volatility of multiple market sectors across previous time periods. Market sector allocations are based on several criteria, including historical profitability, sector balance, and liquidity.
Scott Wright is a long-time speculator with a lifelong passion for the financial markets. Mr. Wright performs research and analysis for Zeal's acclaimed newsletters (http://www.zealllc.com/intelligence.htm) and reports (http://www.zealllc.com/reports.htm). In these newsletters subscribers enjoy cutting-edge market analysis and high-potential trade recommendations.
The Life Sciences Report features leading investment coverage of the life sciences sector, including biotechnology, pharmaceuticals, tools & diagnostics, and medical devices. A Streetwise Reports publication. www.TheLifeSciencesReport.com
Private Investor with 10 years of biotech trading experience.
I use basic disciplined research approach to discover new investment ideas. Biotech sector is full of violent stock moves and trial failures. On one hand it requires traders to be quick on their feet and on the other hand it forces investors to have a great deal of patience.
I enjoy the challenge of mining for hidden gems, because its 10 times as hard to do that than predicting failures. Failure is the norm in biotech, I look for exception to the norm!
Curis, Inc. (CRIS) - NasdaqGM rated best investment going forward in Biotech for the remainder of 2014 and certainly for 2015.
Past Results - Achillion Pharmaceuticals, Inc. (ACHN) was issued a best investment rating on April 14, 2014 and it's hoped that on June 16, 2014 that investors locked in profit near the highs. The high that day was $8.05. The best investment rating was issued from the $2.70's area.
Athersys, Inc. (ATHX) - NasdaqCM In 2013 ATHX in the $1.60's area was issued a best investment notice. Followed up with several articles pointing out its potential. It's hoped investors took profit over $4 in early 2014. Today ATHX and its MultiStem is of high risk with one "no efficacy" phase II trial in 2014 reporting. For this reason ATHX is a buy only under $1.60 again today. This will limit downside to some degree if MultiStem fails again to show efficacy in a second phase II trial.
Other past calls were CLDX, ACUR and ALNY.
Owner and operator of: www.biostockselite.com Have over 15 years of investment experience and interest is dedicated to small cap biotech stocks. Articles submitted to SeekingAlpha will also be posted to my aforementioned site.
JDT investments is an investment group composed of three brothers named John, Joel, and Jacob Damerow. We look for new information, ask questions, and make informed trades based on our research. We deal primarily with small-cap stocks, and are fascinated with the biotech sector as a whole. We wish to present facts to others, and to inform individuals about new changes in the sector. We believe this area offers the greatest potential, if invested in wisely of course, and we strive to distribute that potential to our family, friends, and all of those who are eager to hear our opinions.Long Athersys.
I am an independent equity research analyst and consultant. I focus on finding small-cap biotech stocks where I believe there is favorable risk / reward because of misinformation, lack of information, or a potential fundamental turnaround. I provide detail analysis for investors and investor relations companies. I also provide due diligence and advisory services to companies. Some names I write on I invest in personally and will disclose my position. Names that have hired me to provide due diligence or advisory services I will disclose a business relationship. I previously worked for Zacks Investment Research from 2003 to 2015 as a Senior Biotechnology Analyst. Prior to Zacks, I spent 1999 to 2002 managing money with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology. Prior to joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases, between 1995 and 1998. I also spent a year working at the Fralin Biotechnology Center, and a year working for a cancer researcher while at Virginia Tech. I have a B.S. in Biochemistry from Virginia Tech, with a B.A in Chemistry and a minor in Math. I have a M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University. I hold the Chartered Financial Analyst (CFA) designation.
Chris Orr CCM has been advising traders and investment firms about weather and climate trends for more than 20 years. In his 35+ year career as a meteorologist, he has also forecast weather for power utilities, airlines, corporate aviation, construction, major motion pictures and agriculture. You can follow him on Twitter @ChrisOrrCCM . Chris publishes an e-newsletter about how extreme weather will impact stocks and commodities over the next 1 month to 1-1/2 years. He is a consultant to Precision Profits, a newsletter published by The Sovereign Society (at TheSovereignInvestor.com). Chris was designated a Certified Consulting Meteorologist by the American Meteorological Society in 1997 and is one of about 325 board certified meteorologists. He specializes in long-range extreme weather forecasting using proprietary methods.
Guy Conger is licensed as an Investment Advisor Representative (IAR) and is licensed to sell and/or discuss Advisory Services & Products with anyone residing within the United States. IAR registration is in:
Guy Conger is licensed to sell and/or discuss insurance products only to residents of the states listed below:
Since beginning his career in Money Management Guy has received the designations of Registered Financial Consultant (RFC) and Certified Financial Educator (CFE).
Guy has 15 years of experience in the financial services industry.
Services Offered: Fee Advisory, Financial Planning, Portfolio Management and Risk Management.
Professional Licenses: Series 7, Series 66, Series 63, Series 22, Group 1 Life
Publications: Personal Money Management (self-published) Contributing Columnist- Wiseradvisor.com
Adam Lass is part of the editorial team with Taipan Publishing Group (http://www.taipanpublishinggroup.com/), creator of the WaveStrength Analytic System (http://www.taipanpublishinggroup.com/wavestrength-options.html) and contributor to Taipan Daily (http://www.taipanpublishinggroup.com/profit_with_taipan_daily.html). He has written numerous articles and special investment reports for several major financial publications, including Taipan, Fleet Street, Strategic Investment and Penny Stock Fortunes, on topics ranging from long-term market forecasting, crude oil pricing, and currency speculation to high-tech stocks and precious metals investing.
Taipan Publishing Group LLC and Stansberry & Associates Investment Research are separate companies, and entirely distinct. Their only common thread is a shared parent company, Agora Inc. Agora Inc. was named in the suit by the SEC and was exonerated by the court, and thus dropped from the case. Stansberry & Associates was found civilly liable for a matter that dealt with one writer’s report on a company. The action was not a criminal matter. The case is still on appeal, and no final decision has been made.
I am an individual investor with over 15 years experience in the stock and options markets. I focus on the precious metals, energy, and tech sectors. I believe that there are always opportunities in any kind of market, and I actively look for strategies to take advantage of these opportunities. My long-term outlook is that stock and commodity prices will go higher, and bond prices will go lower. Some of the investing principles that I follow include (1) taking what the market gives you, (2) investing where you have a competitive advantage, (3) having a plan in case a stock goes up or down, and (4) investing only when the odds are in your favor.
Chris DeMuth Jr. is the founder of Rangeley Capital LLC. Rangeley is an investment firm that focuses on event driven, value-oriented investment opportunities. Rangeley Capital and his value investing forum, Sifting the World (StW), search the world for misplaced bets. Rangeley exploits them for its investors and then Mr. DeMuth writes about them on StW.
Bob is retired from a career in law enforcement including more than 20 years as an instructor of Investigative Interviewing. He is a Dividend Growth investor using dividend yield from low beta stocks for income and preservation of capital. Bob has self managed his portfolio since early in 2011. He hopes to encourage discussion among those already in retirement and receiving income from their portfolios.
My curent portfolio is available here: http://seekingalpha.com/article/3969664-difference-quarter-can-make-1st-quarter-portfolio-review?source=all_articles_title
I believe that everyone needs a portfolio business plan. Here's a copy of ours:: http://seekingalpha.com/article/2426965-our-retirement-portfolio-business-plan-legacy-edition-part-two
A list of Dividend Growth Safety Superstars for the past decade is available here: http://seekingalpha.com/article/2255863-a-review-of-the-dividend-safety-superstars http://seekingalpha.com/article/2266863-a-current-review-of-dividend-safety-superstars-part-two
I am a retired engineer with a PhD in Engineering Science (mostly exotic math) together with a Masters in Statistics. I currently manage my website www.superchargeretirementincome.com, where I use my math background to select high-return, low-volatility investments. I also love teaching so I also provide a number of tutorials about all aspects of investing. I am an avid reader and have read just about every book I could find on the stock market. I am still learning so I welcome comments and suggestions. Over the years I have learned that there is no “holy grail”; you cannot receive a good return without taking risks. However, you can choose your investments to reduce risks and those are the kind of investments I like to make. Although financial markets are my passion, engineering is my profession. I have spent the last 30+ years as a program manager at a large aerospace company, working on improving defenses for our U.S. Army customers.
I'm an asset manager at Hebba Alternative Investments with a focus on real assets. In my articles I like to focus on events that affect the macro environment for assets (especially gold and silver), and also introduce readers to different metrics that I believe are under-utilized when assessing investments.
On a more personal note, I'm a firm believer that there can be honesty, morality, and integrity in finance (though its rare) and i'd like to believe that I stick to those principles. Thus I never "pump and dump" stocks, I always list the securities we own, and I take it very seriously when I recommend a company - I do not want to see any investors/readers lose money because of my recommendations.
I'm not always right with recommendations, but investors and readers can know that I always tell the truth (there is no deception) and I eat my own cooking as recommendations are either always owned OR the reason I dont own them is given (usually related to restrictions on stocks I can buy).
Advising people in financial matters is a serious issue and integrity is much more important than money to me, but I do believe both can co-exist. You live with money, but after your death you only have your morality and integrity and thus i've made my choice between the two. A bit philosophical for a bio, but I dont think there's a better way to give investors my background than that.
We offer investors a free weekly email list detailing gold, silver, and general economic markets which you can sign up for at: http://www.communitysynergy.com/subscribe/hebbainvestments_subscribe.html
Retired publisher and dividend investor. He is currently working on a Dividend Investment Project that focuses principally on high-yield stocks with satisfactory histories of sustaining or increasing dividends.